In summary, we conclude that PDLIM2 is required for the migratory capacity of macrophages and full adoption of the M2 phenotype, and that high levels of PDLIM2 in breast cancer tumour and stroma is associated with pro-tumorigenic M2 macrophage activity, particularly in TNBC. Here, PDLIM2 is linked to neoplasm.